$7.0M
The seed round was led by The Discovery Lab of IBA to support product validation and laboratory expansion.
"Advanced diagnostics shouldn’t be gated by geography – the centre of gravity for precision diagnostics needs to shift. We founded Signatur to change the way molecular diagnostics are delivered. This funding brings us closer to ensuring that patients can benefit from precision testing no matter where they are. By turning complex lab processes into simple kits, we’re giving control back to hospitals across Europe and beyond. This funding is a step toward a more resilient and self-sufficient diagnostic ecosystem"